DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundationMRCS

Acute pancreatitis

Essential points for quick revision.

!
Escalate

Increasing oxygen need, hypotension, oliguria, rising creatinine, confusion or acidosis indicates evolving organ dysfunction and requires immediate senior and critical-care reassessment. Jaundice, fever and rigors may indicate concurrent ascending cholangitis, requiring prompt antibiotics and urgent biliary decompression rather than routine pancreatitis observation.

Synopsis

Diagnose acute pancreatic inflammation accurately, establish a cause, deliver evidence-based supportive care and recognise early organ dysfunction or biliary sepsis.

  • Diagnose acute pancreatitis when at least two of three features are present: characteristic pain, serum lipase or amylase above three times the upper reference limit, and compatible imaging.
  • Severe constant epigastric pain commonly radiates to the back and accompanies vomiting, but older, postoperative or critically ill patients can present atypically.
  • Gallstones and alcohol are common causes; also assess medicines, calcium, triglycerides, trauma, recent ERCP, autoimmune disease, infection, anatomical obstruction and tumour.

Key red flags

Evolving organ dysfunction

Increasing oxygen need, hypotension, oliguria, rising creatinine, confusion or acidosis signals systemic severity and requires senior and critical-care reassessment.

Investigation priorities

01
Serum lipase or amylaseFirst step

Provide one diagnostic criterion in a patient with compatible acute upper-abdominal pain.

Management branches

InitialFirst-day supportive care

Two diagnostic criteria establish pancreatitis or the clinical probability is high while confirmation proceeds.

  1. Use ABCDE, prescribe appropriate monitored analgesia and antiemesis, correct hypoxaemia and establish venous access plus urine-output observation.
  2. Give crystalloid for demonstrable hypovolaemia in reassessed increments, considering age, heart or kidney disease and signs of pulmonary congestion.

Key medicines

Opioid analgesiaTitrate a short-acting intravenous, subcutaneous or oral regimen under the acute-pain protocol with frequent effect and sedation review.
Crystalloid fluid replacementGive reassessed adult boluses or maintenance matched to perfusion, urine output, losses, comorbidity and local intravenous-fluid guidance.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom